(Q53119067)
Statements
The Combination of Sorafenib and Everolimus Abrogates mTORC1 and mTORC2 upregulation in osteosarcoma preclinical models (English)
Marco Basiricò
Marco Soster
Stefania Bruno
Loretta Gammaitoni
Lorenzo D'Ambrosio
Stefano Ferrari
Marco Alberghini
22 February 2013